Enhancement of antibody-dependent cellular cytotoxicity of cetuximab by a chimeric protein encompassing interleukin-15

Enhancement of antibody-dependent cellular cytotoxicity (ADCC) may potentiate the antitumor efficacy of tumor-targeted monoclonal antibodies. Increasing the numbers and antitumor activity of NK cells is a promising strategy to maximize the ADCC of standard-of-care tumor-targeted antibodies. For this...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncoimmunology
Main Authors: Ochoa, Maria Carmen, Minute, Luna, López, Ascensión, Pérez-Ruiz, Elisabeth, Gomar, Celia, Vasquez, Marcos, Inoges, Susana, Etxeberria, Iñaki, Rodriguez, Inmaculada, Garasa, Saray, Mayer, Jan-Peter Andreas, Wirtz, Peter, Melero, Ignacio, Berraondo, Pedro
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2017
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5749662/
https://ncbi.nlm.nih.gov/pubmed/29308327
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2017.1393597
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados